Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $10000.0.

  • Standard Biotools' Interest Expenses fell 9882.77% to $10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $593000.0, marking a year-over-year decrease of 8456.53%. This contributed to the annual value of $3.3 million for FY2024, which is 2739.22% down from last year.
  • Latest data reveals that Standard Biotools reported Interest Expenses of $10000.0 as of Q3 2025, which was down 9882.77% from $9000.0 recorded in Q2 2025.
  • In the past 5 years, Standard Biotools' Interest Expenses ranged from a high of $1.2 million in Q3 2023 and a low of $2000.0 during Q1 2025
  • Its 5-year average for Interest Expenses is $789473.7, with a median of $968000.0 in 2021.
  • As far as peak fluctuations go, Standard Biotools' Interest Expenses soared by 165084.75% in 2024, and later crashed by 9980.64% in 2025.
  • Quarter analysis of 5 years shows Standard Biotools' Interest Expenses stood at $1.1 million in 2021, then grew by 11.01% to $1.2 million in 2022, then dropped by 7.73% to $1.1 million in 2023, then crashed by 47.91% to $572000.0 in 2024, then plummeted by 98.25% to $10000.0 in 2025.
  • Its Interest Expenses was $10000.0 in Q3 2025, compared to $9000.0 in Q2 2025 and $2000.0 in Q1 2025.